Insights

Latest thinking from our team

Expert perspectives on real-world evidence, health economics, and AI in life sciences.

July 2026

Revagenix’s Rev-56 Enters Phase 1: Why Bronchiectasis Evidence Strategy Must Start Before Efficacy Data

Revagenix’s Rev-56 Enters Phase 1: Why Bronchiectasis Evidence Strategy Must Start Before Efficacy Data Revagenix announced on 27 July 2026 that the first...

June 2026

Vision, Missionand Core Values

The PROGRESS frame work can be implied for the identification and classification of equity-relevant data. It can aid researchers to consider equity while planni...

June 2026

RANKS PRESENTED TO CADETS IN A PIPPING CEREMONY

PROGRESS Framework for Health Equity The PROGRESS frame work can be implied for the identification and classification of equity-relevant data. It can aid resear...